Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(64)
•••
venture009
X
View Profile
View Bullboard History
Post by
venture009
on Apr 11, 2024 5:36pm
2024 Pivotal Year
Dr. Coffey has once again proclaimed 2024 to be a "pivotal year". Load up!
(135)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Apr 11, 2024 5:25pm
RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
You forever pumpers need to go stand in front of a mirror and point the finger at the problem. I would not have gotten down on your level if you had let folks have their view even though you don't
...more
Coelacanth Announces 2023 Year-End Reserves
posted Apr 19, 2024 9:00am by
Coelacanth Energy Inc.
-
|
During 2023, Coelacanth completed successful Montney pad wells at both Two Rivers West and Two Rivers East. Longer wells and a new completion design was successfully executed on both pads resulting in materially improved productivity. Baseline productivity was established in the Upper Montney at Two Rivers West and the Lower and Basal Montney at Two Rivers East for future adjustments to completions and well designs ...read more
(1153)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 11, 2024 5:00pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
So you've held a biotech for 25 years and haven't picked up any understanding of how any of this works? I think that's a shame on you scenario!!
(36)
•••
jh1970
X
View Profile
View Bullboard History
Comment by
jh1970
on Apr 11, 2024 4:44pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
After holding shares more then 25 years and loosing tenth of thousandth of dollars I have bad experience with ONC managment , which us a news and is doing something diffrent .
(50)
•••
Journeytc
X
View Profile
View Bullboard History
Comment by
Journeytc
on Apr 11, 2024 4:41pm
RE:Type C Meeting Timings
Great news....truly. I think the FDA will accomodate a meeting within a month and a half. I'm guessing this means ONC met key performance leaders? No guidance
...more
(1153)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 11, 2024 4:29pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Did you go read why your type B and type A comment earlier was really stupid? What do you have to say for yourself?
(36)
•••
jh1970
X
View Profile
View Bullboard History
Comment by
jh1970
on Apr 11, 2024 4:14pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Question : why they don`t give a names of partners and collaborators ?
(812)
•••
canadafan
X
View Profile
View Bullboard History
Comment by
canadafan
on Apr 11, 2024 3:08pm
RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
A quick search shows without any doubt, the every single post buckhenry has ever posted has been an attack on another person or Onc as a company. Clearly his motive is ti distract from any positive
...more
(306)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Apr 11, 2024 2:42pm
RE:RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Hey buck....grow up.
(5098)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 11, 2024 2:40pm
RE:RE:RE:RE:“Second mouse gets the cheese “
Correction: BioNTech / Genentech's Phase 2 mRNA "vaccine" clinical trial involving adjuvant autogene cevumeran in combination with the anti-PD-L1 immune checkpoint inhibitor
...more
(135)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Apr 11, 2024 2:35pm
RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
For those thar can't see the bigger picture... unnoteable will post more worthless garbage in an effort to boost his ego.... even more... if that's possible..
(5098)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 11, 2024 1:22pm
RE:RE:RE:“Second mouse gets the cheese “
For those who can't see the larger picture BioNTech / Genentech's Phase 2 mRNA "vaccine" clinical trial involving adjuvant autogene cevumeran in combination with the anti
...more
(1153)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 11, 2024 12:39pm
RE:RE:RE:RE:RE:RE:RE:Type C Meeting Timings
That is funny because you're the lowest common denominator.
(135)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Apr 11, 2024 12:36pm
RE:RE:RE:RE:RE:RE:Type C Meeting Timings
Funny... they asked me go down to the lowest common denominator...and that is the forever blind pumpers here...
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors
The Increasing Investments by the Defense and Military Sectors is Driving the Demand for Helium
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%